Herpes Simplex (ICD-10: B00) ⚠️

Herpes Simplex Virus (HSV-1 and HSV-2): Clinical Overview and Management

General Characteristics

Herpes simplex is a widespread viral infection caused by DNA-containing herpes simplex viruses (HSV), classified in the ICD-10 under codes B00 (Herpesviral infections) and A60 (Anogenital herpesviral infection). These viruses have the ability to establish latency in the human nervous system after initial infection and may reactivate periodically under favorable conditions. Reactivation episodes often coincide with physiological or environmental triggers such as intercurrent illness or fever, local skin trauma, psychological stress, and immunosuppression. Many recurrences have no identifiable trigger, and the pattern differs from person to person.

Once the virus enters the body, it replicates locally in the epithelial tissue of the skin or mucous membranes. It then travels retrograde via sensory neurons to the dorsal root or trigeminal ganglia, where it becomes latent. The virus can persist in this dormant state indefinitely, reactivating spontaneously or in response to external stressors to cause recurrent lesions in the original site of infection.

Etiology: HSV-1 and HSV-2

There are two distinct types of herpes simplex virus:

• HSV-1 (Herpes Simplex Virus Type 1): Primarily associated with oral and facial infections, particularly labial herpes, but can also cause genital infections through oral-genital contact.
• HSV-2 (Herpes Simplex Virus Type 2): Most commonly responsible for genital herpes, but can also infect the orofacial area in certain cases.

Both HSV-1 and HSV-2 are highly contagious and capable of causing acute symptomatic outbreaks as well as asymptomatic viral shedding, which contributes significantly to the spread of infection. Importantly, both virus types can result in primary and recurrent disease in either the oral or genital region, depending on the mode of transmission.

Clinical Manifestations

Herpes simplex infection typically presents as clusters of small, fluid-filled blisters (vesicles) on a red, swollen base. The vesicles are dome-shaped, ranging in size from 1–3 mm, often grouped, and are typically painful. Over the following days they rupture to leave shallow erosions or ulcers, which crust over and heal within 7–14 days. The fluid may become cloudy as lesions age; frankly purulent or haemorrhagic change is possible but is not a usual part of the sequence, and its presence should prompt consideration of secondary bacterial infection.

Common locations include:

• HSV-1: Perioral region (lips, nose, cheeks), gingiva, palate, tongue, or facial skin;
• HSV-2: Genital and perineal region, buttocks, thighs, urethra, cervix, and vagina.

Subjective symptoms may include:

• Itching, tingling, or burning prior to the appearance of lesions (prodrome);
• Localized pain or discomfort in affected areas;
• Fever, fatigue, headache, and lymphadenopathy (especially in primary infections);
• Neuralgic pain: Especially common in genital herpes, often affecting the perineum, glans penis, or labia.

New blisters tend to appear in close proximity to initial lesions and may evolve over several days. Recurrent infections are usually milder and shorter in duration than the primary episode.

Diagnosis of Herpes Simplex Virus Infections

Although diagnosis is often based on the characteristic appearance of lesions and patient history, laboratory confirmation is essential in atypical cases, immunocompromised individuals, or when differentiating herpes from other ulcerative genital or oral conditions.

Recommended diagnostic methods include:

• PCR / NAAT from a lesion swab: The preferred test when laboratory confirmation is needed. It detects and types HSV DNA, and is also used on cerebrospinal fluid where central nervous system involvement is suspected.
• Viral culture: Highly specific, but considerably less sensitive than PCR — particularly in recurrent episodes and in lesions that have begun to heal.
• Direct Fluorescent Antibody (DFA) Testing: Identifies viral antigens in lesion material and gives a rapid result, but is not a preferred routine test where PCR is available.
• Type-specific serology (IgG): Used selectively — for example to establish whether a partner in a relationship is already infected, or to clarify an atypical history. It is not a general screening test for people entering new relationships, and it cannot tell you where or when infection was acquired.

In cases of genital ulceration, differential diagnosis must include syphilis, chancroid, aphthous ulcers, and Behçet’s syndrome, among others. Therefore, combined clinical and laboratory approaches are the gold standard for accurate diagnosis.

Treatment of Herpes Simplex

While there is no cure for HSV infection, effective antiviral medications can significantly reduce the severity, duration, and recurrence rate of outbreaks. The choice of drug and dosing regimen depends on whether the infection is primary, recurrent, or prophylactic (suppressive).

Antiviral Medications:

• Acyclovir: The most widely used antiviral, available in oral, topical, and intravenous forms;
• Valacyclovir: A prodrug of acyclovir with better oral bioavailability, allowing for less frequent dosing;
• Famciclovir: An alternative with similar efficacy and good absorption characteristics.

Therapeutic approaches:

• Episodic treatment: A short oral course, most effective when started at the prodrome — the tingling or burning that precedes lesions — or at the very onset of the rash. Starting later in an established outbreak gives less benefit.
• Suppressive therapy: Daily oral antiviral treatment. The decision rests on the burden of recurrences, the patient’s own preference, and concern about transmission to a partner, considered together — not on serodiscordance by itself.
• Topical antivirals: Offer limited benefit compared with oral therapy and are not a substitute for it.

In severe or complicated HSV infections (e.g., encephalitis, neonatal herpes, or disseminated disease), hospitalization and intravenous antiviral therapy may be required.

Prevention of Herpes Simplex Virus Infections

Preventing HSV transmission relies on a combination of behavioral precautions, barrier protection, partner communication, and immune system support. While complete prevention of herpes simplex transmission may not always be possible, the following strategies significantly reduce the risk of infection or reactivation:

Primary Prevention: Avoiding Initial Infection

• Consistent use of condoms: While not 100% protective, condoms reduce the risk of transmission by limiting skin-to-skin contact with infected areas.
• Avoiding sexual contact during active outbreaks: HSV shedding is highest when lesions are present; abstinence during flare-ups is essential.
• Partner disclosure: Inform sexual partners of known HSV infection and discuss testing for both HSV-1 and HSV-2.
• Transmission without visible lesions: HSV can be passed on during asymptomatic shedding, when the skin looks entirely normal. Avoiding contact during outbreaks lowers the risk but does not remove it.
• Testing: Routine HSV blood testing is not recommended as part of a general STI screen in the absence of a clinical indication. Where there are symptoms, a swab of the lesion for PCR is the appropriate test.

Secondary Prevention: Reducing Recurrence and Transmission

For individuals already infected with HSV, the goal is to minimize outbreaks and reduce the chance of spreading the virus to others. Recommendations include:

• Daily antiviral prophylaxis: For patients with frequent recurrences or in serodiscordant couples, suppressive therapy with acyclovir, valacyclovir, or famciclovir is highly effective in reducing outbreaks and asymptomatic shedding.
• Identifying and avoiding personal triggers: Maintain a journal to track the onset of symptoms and correlate with stress, illness, or lifestyle changes.
• Immune system support: Balanced nutrition, adequate rest, stress reduction techniques, and treatment of chronic illnesses help reduce reactivation risk.
• Avoiding skin trauma: Friction during intercourse, shaving, or abrasive clothing may trigger outbreaks, especially in the genital region.

Conclusion

Herpes simplex virus (both HSV-1 and HSV-2) is a pervasive and lifelong infection with significant implications for physical and emotional well-being. Despite the absence of a definitive cure, modern antiviral treatments provide reliable control over symptoms, reduce transmission risk, and allow most individuals to lead normal, fulfilling lives.

Through early diagnosis, education, preventive strategies, and tailored therapeutic regimens, both primary and recurrent HSV infections can be effectively managed. Public awareness and responsible sexual behavior remain critical components in reducing the global burden of herpes simplex infections.

Individuals who suspect HSV infection—or are managing known herpes—should work closely with healthcare providers to establish personalized care plans and maintain optimal skin and sexual health.